Skip to content
DefDex

Federal award

DIASORIN INC

W81K0024P0169

Contract

Obligated and Ceiling

Obligated (net)
$505,892.81
Ceiling (potential value, not spending)
$1,997,177.61
Current value
$1,072,912.33
Gross positive obligations
$523,045.28

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
DIASORIN INC · FGK2QR959BV5
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
DIASORIN S.P.A. · KN6PH2K51SJ6
Awarding agency
Department of War · sub-agency 2100 · office W81K00
Funding agency
Department of War · sub-agency 97DH
Product or service (PSC)
6505 · DRUGS AND BIOLOGICALS
Industry (NAICS)
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
PIID
W81K0024P0169
Award type code
B
Actions
8 · Aug 21, 2024 to Jun 25, 2026
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History8

Award actions
DateFYModAction typeObligationCompany in company totals
Jun 25, 2026FY2026P00007C−$12,883.85
—
Jun 3, 2026FY2026P00006G$0.00
—
May 6, 2026FY2026P00005M$0.00
—
Dec 31, 2025FY2026P00004C$261,522.64
—
Aug 25, 2025FY2025P00003G$0.00
—
Aug 19, 2025FY2025P00002B−$4,268.62
—
Oct 29, 2024FY2025P00001C$261,522.64
—
Aug 21, 2024FY20240—$0.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.